Pharma news
Americas
The US Patent Trial and Appeal Board has instituted inter partes reviews of two patents owned by Sanofi covering Lantus (insulin glargine injection). 20 December 2017
Pharma
The European Commission has closed an investigation into Roche which centred on the company’s pharmacovigilance duties. 19 December 2017
Americas
WilmerHale has promoted Heather Petruzzi and Andrew Danford to partner. 19 December 2017
Pharma
While the impact of the European Medicines Agency’s relocation from London to Amsterdam is unknown, industry and government will try to ensure that the UK remains at the forefront of medicines regulation, says Rachel Bradley of Penningtons Manches. 15 December 2017
Pharma
France-headquartered Sanofi presented key updates to its research and development strategy yesterday, outlining three key shifts. 15 December 2017
Pharma
The EU General Court has dismissed an appeal from a Spanish laboratory which had sought to have part of a European Union Intellectual Property Office trademark decision annulled. 14 December 2017
Americas
Allergan has boosted its focus on women’s health with the acquisition of Repros Therapeutics, a development stage biopharmaceutical company. 13 December 2017
Americas
Forest Laboratories, a subsidiary of Allergan, has failed in its attempt to overturn a district court ruling in its patent battle with Teva. 13 December 2017
Pharma
Teva has dropped its litigation over two US patents against Mylan, after a district court adopted Mylan’s interpretation of the patents. 12 December 2017
Pharma
The UK government has announced a deal between the life sciences sector and the government, aimed at ensuring that the “next wave of breakthrough treatments” and innovative medical research and technologies are created in the country. 11 December 2017